The price of cystic fibrosis drugs is still too high

27 January 2022 - The Swedish Dental and Pharmaceutical Benefits Agency, TLV, has decided that Kaftrio and Kalydeco for cystic fibrosis ...

Read more →

Do federal price transparency regulations neglect oncology patients?

24 January 2022 - The National Cancer Institute has identified measuring, understanding, and addressing cancer-related patient financial hardship as a top ...

Read more →

2022 April price disclosure cycle – indicative prices

27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...

Read more →

CMS takes action to lower out of pocket Medicare Part D prescription drug costs

6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to ...

Read more →

Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices?

3 January 2022 - Astellas Pharma, a drug company headquartered in Japan, is charging U.S. patients $156,000 a year for ...

Read more →

Biogen cuts price for Alzheimer’s drug Aduhelm by half

20 December 2021 - The drug has sold poorly since its approval in June due to concerns about its safety, effectiveness ...

Read more →

Why the big questions about drug prices are rarely asked: it’s hard to do

16 December 2021 - Public debate over legislation to allow Medicare to negotiate the price of drugs has been dominated ...

Read more →

FTC takes 'Pharma Bro' Martin Shkreli to trial over drug price hike

14 December 2021 - Shkreli is accused of masterminding an illegal scheme to jack up prices of the lifesaving drug Daraprim ...

Read more →

‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit

10 December 2021 - It was the day before Christmas in 2015 and a senior director of national accounts at ...

Read more →

Price disclosure 2022 April cycle outcomes summary

10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...

Read more →

Don’t destroy future drug development

8 December 2021 - With support faltering for the massive big-government blowout Congress is trying to jam through by Christmas, ...

Read more →

PhRMA statement on White House drug pricing event

6 December 2021 - Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl released the following statement ...

Read more →

$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now

8 December 2021 - A new $56,000 a year Alzheimer’s medication that’s leading to one of the biggest increases ever in ...

Read more →

Remarks by President Biden on prescription drug costs

6 December 2021 - Today, I’d like to talk about how we’re going to help millions of Americans protect and ...

Read more →

Drug makers cut prices by 62% on average to get China state insurance listing

4 December 2021 - Pharmaceutical firms have agreed to cut prices by 61.7% on average for 67 medicines to be ...

Read more →